摘要
目的:总结采用经支气管镜支气管黏膜下注射硬化剂-1%乙氧硬化醇治疗肺切除术后支气管胸膜瘘的临床经验。方法:8例支气管胸膜瘘患者接受经支气管镜注射硬化剂的治疗。8例中,全肺切除术后2例,肺叶切除术后6例。结果:6例患者获得痊愈,无手术相关并发症发生。结论:经支气管镜支气管黏膜下注射硬化剂治疗支气管胸膜瘘是一种安全、有效的方法,值得在临床上推广。
Objective:To summarize our experience on treatment of bronchopleural fistula through submucosal injection of sclerosing agent -1% polidocanol using flexible bronchoscope, Methods: 8 patients with postoperative bronchopleural fistula were treated by submucosal injection of sclerosing agent through bronchoscopy, including 2 post-pneumonectomy patients and 6 post-lobectomy patients, Results: 6 patients were cured successfully with no complications Conclusion: Submucosal injection of sclerosing agent-1%polidocanol through flexible bronchoscope is a safe and effective method, thus worth recommending.
出处
《中国临床医学》
北大核心
2006年第3期384-385,共2页
Chinese Journal of Clinical Medicine
关键词
支气管胸膜瘘
内镜
纤维支气管镜
硬化剂
Bronchopleural fistula
Endoscopy
Bronchoscopy
Sclerosing agent